Alcon [ALC] vs Hologic [HOLX] Detailed Stock Comparison

Alcon Inc.

NYSE
Loading...

Hologic Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Alcon Inc. wins in 7 metrics, Hologic Inc. wins in 12 metrics, with 0 ties. Hologic Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Alcon Inc. Hologic Inc. Better
P/E Ratio (TTM) 40.84 31.54 Hologic Inc.
Price-to-Book Ratio 2.07 3.23 Alcon Inc.
Debt-to-Equity Ratio 23.63 48.05 Alcon Inc.
PEG Ratio 26.11 -3.92 Alcon Inc.
EV/EBITDA 21.16 12.68 Hologic Inc.
Profit Margin (TTM) 11.28% 13.18% Hologic Inc.
Operating Margin (TTM) 13.30% 22.99% Hologic Inc.
EBITDA Margin (TTM) 13.30% 22.99% Hologic Inc.
Return on Equity 5.23% 10.86% Hologic Inc.
Return on Assets (TTM) 2.74% 7.43% Hologic Inc.
Free Cash Flow (TTM) $1.41B $904.70M Alcon Inc.
1-Year Return -22.45% 31.39% Hologic Inc.
Price-to-Sales Ratio (TTM) 4.62 4.11 Hologic Inc.
Enterprise Value $49.36B $17.12B Alcon Inc.
EV/Revenue Ratio 4.97 4.15 Hologic Inc.
Gross Profit Margin (TTM) 55.92% 55.96% Hologic Inc.
Revenue per Share (TTM) $20 $18 Alcon Inc.
Earnings per Share (Diluted) $2.25 $2.41 Hologic Inc.
Beta (Stock Volatility) 0.70 0.70 Alcon Inc.
Short % of Float N/A 3.66% N/A

Alcon Inc. vs Hologic Inc. Stock Performance Analysis

Loading Price Chart...

ALC
HOLX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alcon Inc.-0.84%0.27%4.16%-14.78%-16.29%-14.57%
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alcon Inc.-22.45%-17.74%-4.83%22.82%22.82%22.82%
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%

Performance & Financial Health Analysis: Alcon Inc. vs Hologic Inc.

MetricALCHOLX
Market Information
Market Cap i$45.84B$16.97B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,498,68012,273,085
90 Day Avg. Volume i1,604,6036,282,625
Last Close$66.29$76.01
52 Week Range$61.83 - $92.55$51.90 - $76.07
% from 52W High-28.37%-0.08%
All-Time High$101.10 (Sep 09, 2024)$87.88 (May 01, 2023)
% from All-Time High-34.43%-13.51%
Growth Metrics
Quarterly Revenue Growth0.01%0.03%
Quarterly Earnings Growth0.41%-0.11%
Financial Health
Profit Margin (TTM) i0.11%0.13%
Operating Margin (TTM) i0.13%0.23%
Return on Equity (TTM) i0.05%0.11%
Debt to Equity (MRQ) i23.6348.05
Cash & Liquidity
Book Value per Share (MRQ)$44.39$23.51
Cash per Share (MRQ)$2.85$10.60
Operating Cash Flow (TTM) i$2.12B$1.10B
Levered Free Cash Flow (TTM) i$1.18B$848.61M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Alcon Inc. vs Hologic Inc.

MetricALC (Jul 26, 2025)HOLX (Apr 19, 2026)
Price Ratios
P/E Ratio (TTM) i40.8431.54
Forward P/E i26.1115.64
PEG Ratio i26.11-3.92
Price to Sales (TTM) i4.624.11
Price to Book (MRQ) i2.073.23
Market Capitalization
Market Capitalization i$45.84B$16.97B
Enterprise Value i$49.36B$17.12B
Enterprise Value Metrics
Enterprise to Revenue i4.974.15
Enterprise to EBITDA i21.1612.68
Risk & Other Metrics
Beta i0.700.70
Book Value per Share (MRQ) i$44.39$23.51

Financial Statements Comparison: Alcon Inc. vs Hologic Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALC (2024)HOLX (2025)
Revenue/Sales i9.91B4.10B
Cost of Goods Sold i4.40B1.98B
COGS % of Revenue i44.4%48.4%
Gross Profit i5.51B2.12B
Gross Margin i55.6%51.6%
Research & Development i876.00M248.20M
Operating Income (EBIT) i1.41B785.40M
Operating Margin i14.3%19.2%
EBITDA i2.71B1.17B
EBITDA Margin i27.3%28.5%
Pre-Tax Income i1.26B681.20M
Pre-Tax Income % of Revenue i12.7%16.6%
Income Tax i238.00M115.50M
Income Tax % of Revenue i2.4%2.8%
Net Income (Profit) i1.02B565.70M
Profit Margin i10.3%13.8%

Balance Sheet & Liquidity Metrics

MetricALC (2024)HOLX (2025)
Cash & Equivalents i1.68B1.96B
Total Current Assets i6.31B3.67B
Total Current Assets % of Revenue i63.7%89.5%
Total Current Liabilities i2.28B977.20M
Total Current Liabilities % of Revenue i23.0%23.8%
Long-Term Debt i4.97B2.59B
Long-Term Debt % of Revenue i50.1%63.2%
Total Shareholders Equity i21.55B5.05B
Retained Earnings iN/A3.41B
Retained Earnings % of Revenue i0.0%83.2%
Property, Plant & Equipment i36.00M1.07B

Cash Flow Statement Comparison

MetricALC (2024)HOLX (2025)
Operating Cash Flow i2.50B831.50M
Operating Cash Flow % of Revenue i25.2%20.3%
Capital Expenditures i-473.00M-78.20M
Free Cash Flow i1.41B904.70M
FCF Margin i14.2%22.1%
Debt Repayment i-196.00M-1.20B
Common Stock Repurchase iN/A-752.90M

Short Interest & Institutional Ownership Analysis

MetricALCHOLX
Shares Short i6.89M7.10M
Short Ratio i4.542.78
Short % of Float iN/A3.66%
Shares Outstanding i494.62M223.07M
Float Shares i494.60M221.21M
% Held by Insiders i0.13%0.84%
% Held by Institutions i68.80%96.52%
% Held by Public i31.07%2.64%

Dividend Analysis & Yield Comparison: Alcon Inc. vs Hologic Inc.

MetricALCHOLX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.17N/A
3-Year Avg Dividend Yield i0.30%N/A
3-Year Total Dividends i$0.50N/A
Ex-Dividend DateMay 14, 2024N/A